Origen de la red de primer grado Anthony Kouzarides.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
17
| Public Company | Biotechnology | 17 |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom.
13
| Holding Company | Biotechnology | 13 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Anthony Kouzarides a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| University of Cambridge | College/University | Graduate Degree Graduate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree | |
Cambridge Innovation Capital Ltd
 Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Chief Executive Officer Consultant / Advisor Private Equity Investor | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Cambridge Nutraceuticals Ltd.
 Cambridge Nutraceuticals Ltd. Pharmaceuticals: OtherHealth Technology Cambridge Nutraceuticals Ltd. engages in providing natural health supplements. Its products include Ateronon Heart Health, Ateronon XY and Ateronon Active. The company is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Chairman Director/Board Member Director/Board Member | |
Axol Bioscience Ltd.
 Axol Bioscience Ltd. BiotechnologyHealth Technology Axol Bioscience Ltd. is a biotech company that develops and produces induced pluripotent stem cell-derived clinically relevant cells for use in biomedical research and discovery. Its products include human neural progenitor cells, young frozen human cerebral cortical neurons, plated human cerebral cortical neurons, Alzheimer's disease human neural progenitor cells, reagents, and lipid-based transfection reagents. The firm's products are used in the testing of new drug compounds, as well as in the development of therapies for various diseases, such as Alzheimer’s. The company was founded by Yichen Shi and Jonathan Simon Milne and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Founder Director/Board Member | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Analysys Ltd.
 Analysys Ltd. Miscellaneous Commercial ServicesCommercial Services Analysys Ltd. provides consulting services in the strategy, management and information technology fields. The company was founded in 1984 and is headquartered in Manchester, the United Kingdom. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chairman | |
| QUARTIX TECHNOLOGIES PLC | Electronics Distributors | Director/Board Member Chief Operating Officer | |
Cambridge Enterprise Ltd.
 Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Investment Managers | Investment Committee Member Private Equity Investor | |
| London Business School | College/University | Masters Business Admin Corporate Officer/Principal | |
| The University of Sheffield | College/University | Doctorate Degree Doctorate Degree | |
| AVACTA GROUP PLC | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Start Codon Ltd.
 Start Codon Ltd. Investment ManagersFinance Start Codon Ltd (Start Codon) is a venture capital firm founded in 2018 by Jason Mellad and Marek Tyl. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member Director/Board Member | |
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pfizer Venture Investments LLC
 Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments LLC (Pfizer Ventures Investments) is a venture capital subsidiary of Pfizer Inc. founded in 2001. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Founder | |
Prelude Trust Plc
 Prelude Trust Plc Investment ManagersFinance Prelude Trust Plc invests in technology and life science companies located in the UK. It targets companies operating in the fields of information technology, communications, advanced materials, sensors, displays & semiconductors, healthcare, drug discovery and medical devices. It provides financing for seed and early stage capital requirements. | Investment Managers | Director/Board Member Director/Board Member | |
Congenica Ltd.
 Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Biotechnology | Director/Board Member Chief Investment Officer | |
Horizon Discovery Ltd.
 Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Polyprox Therapeutics Ltd.
 Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
| DOMESTIC & GENERAL GROUP PLC | Other Consumer Services | Director/Board Member | |
DynamicAction Holdings, Inc.
 DynamicAction Holdings, Inc. Internet Software/ServicesTechnology Services DynamicAction Holdings, Inc. operates as an online platform which provides sharing retail data services to retail experts and engineers, data scientists, and marketers. The company was founded by Michael Ross in 2007 and is headquartered in Redwood City, CA. | Internet Software/Services | Founder | |
In Kind Direct
 In Kind Direct Wholesale DistributorsDistribution Services In Kind Direct distributes consumer goods. The company was founded in 1997 and is headquartered in London, the United Kingdom. | Wholesale Distributors | Director/Board Member | |
| Maths & Magic Ltd. | Director/Board Member | ||
| N BROWN GROUP PLC | Apparel/Footwear Retail | Director/Board Member | |
Qkine Ltd.
 Qkine Ltd. Pharmaceuticals: OtherHealth Technology Qkine Ltd. provides growth factors and bioactive proteins for use in stem cell science and regenerative medicine applications. Its products include Activin A and FGF2. The firm specializes in protein purification, organoids, cytokines, and protein-engineering. The company was founded by Marko Hyvonen and Catherine Elton in 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
Spirea Ltd.
 Spirea Ltd. BiotechnologyHealth Technology Spirea Ltd. operates as a healthcare technology company. It develops smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines. The company was founded by Myriam Ouberai and is headquartered in arrogate, the United Kingdom. | Biotechnology | Director/Board Member | |
| Alan Turing Institute | Corporate Officer/Principal | ||
Pharmenable Ltd.
 Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| TREATT PLC | Chemicals: Specialty | Director/Board Member | |
SDS Therapeutics Ltd.
 SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK. | Miscellaneous Commercial Services | Director/Board Member | |
| St. Minver Ltd. | Director of Finance/CFO | ||
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Epitopea Ltd.
 Epitopea Ltd. Miscellaneous Commercial ServicesCommercial Services Epitopea Ltd. is a British transatlantic biotechnology company that develops immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. The company is based in Cambridge, UK. The company has an extensive proprietary library of cryptigen™ tsas that will drive the development of transformational off the shelf cancer immunotherapies. Epitopea was founded in 2021 by Jonathan David Moore, Claude Perreault, and Pierre Thibault. Jonathan David Moore has been the CEO since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
The Cambridge Arts Theatre Trust Ltd.
 The Cambridge Arts Theatre Trust Ltd. Movies/EntertainmentConsumer Services The Cambridge Arts Theatre Trust Ltd. operates as a theatre that presents a varied mix of drama, dance, opera and pantomime. The company was founded on March 27, 1998 and is headquartered in Cambridge, the United Kingdom. | Movies/Entertainment | Director/Board Member | |
Oxford Capital Partners LLP
 Oxford Capital Partners LLP Investment ManagersFinance Oxford Capital Partners LLP (Oxford Capital Partners) is a venture capital subsidiary of Oxford Capital Partners Holdings Ltd founded in 1999 by Tedd Mott and David Edward Christian Mott. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Private Equity Analyst | |
Buckman Laboratories SARL
 Buckman Laboratories SARL Chemicals: Major DiversifiedProcess Industries Buckman Laboratories SARL wholesales chemicals to the paint industry. The firm markets its products under the brand names such as BUCKMAN, BUFLOC, BULAB, BUSAN, BUSPERSE, and BUTROL. The company was founded on December 21, 2007 and is headquartered in Wasquehal, France. | Chemicals: Major Diversified | Director/Board Member | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
Sense Biodetection Ltd.
 Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Proteorex Therapeutics, Inc.
 Proteorex Therapeutics, Inc. BiotechnologyHealth Technology Proteorex Therapeutics, Inc. develops novel therapeutics. It is discovering small-molecule drugs to treat diseases with the greatest unmet medical need. The firm’s drug discovery platform integrates a novel synthesis design strategy, machine learning, and patient-derived cell-based screening to unlock targets considered undruggable using existing approaches. The company was founded by Aman Iqbal, Kong T. Nguyen, Robert Batey and Michael Anstey and is headquartered in Toronto, Canada. | Biotechnology | Founder | |
| Queen's University | College/University | Undergraduate Degree | |
| PONIARD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
MyOptique Group Ltd.
 MyOptique Group Ltd. Specialty StoresRetail Trade MyOptique Group Ltd. operates as an online prescription eyewear store. It offers prescription glasses, sunglasses, and contact lenses for men and women. The company was founded by Jamie Murray Wells in 2004 and is headquartered in Swindon, the United Kingdom. | Specialty Stores | Director/Board Member |
Estadísticas
Internacional
| Reino Unido | 41 |
| Estados Unidos | 6 |
| Canadá | 3 |
| Dinamarca | 2 |
| Francia | 2 |
Sectorial
| Health Technology | 20 |
| Consumer Services | 8 |
| Finance | 7 |
| Commercial Services | 7 |
| Distribution Services | 3 |
Operativa
| Director/Board Member | 207 |
| Chairman | 51 |
| Corporate Officer/Principal | 49 |
| Independent Dir/Board Member | 32 |
| Chief Executive Officer | 25 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Elaine Jones | 37 |
| Anthony Francis Martin | 30 |
| Jonathan Milner | 26 |
| Peter Stephen Keen | 25 |
| Bobby G. Soni | 23 |
| Hakan Goker | 18 |
| Michael Ross | 18 |
| John Sørensen Haurum | 17 |
| Tim Edwards | 16 |
| Mark John Alexander Webster | 15 |
| Michael Anstey | 14 |
| David Douglas Cleevely | 14 |
| Gerald McMahon | 13 |
| Sakae Asanuma | 12 |
| Murray Edwin Hennessy | 11 |
- Bolsa de valores
- Insiders
- Anthony Kouzarides
- Conexiones Empresas
